Tag Archive | "Biogen Idec"

Biogen Idec enters hemophilia academic research pact

Tags: , , ,


Biogen Idec, Fondazione Telethon and Ospedale San Raffaele have entered into a worldwide collaboration to jointly develop gene therapies for the treatment of both hemophilia A and B Read the full story

Biogen Idec acquires Convergence Pharmaceuticals

Tags: , ,


Biogen Idec plans to leverage Convergence’s expertise in chronic pain research and clinical development to accelerate the growth of its pain portfolio Read the full story

Sobi and Biogen Idec sign a pharma deal for hemophilia

Tags: , , ,


Swedish Orphan Biovitrum has elected to add the preclinical rFVIIIFc-XTEN-vWF fusion molecule to the company's pharma deal with Biogen Idec. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Biogen Idec

Tags: , , , ,


Biogen Idec is a top pharmaceutical/biotechnology company based in Weston, MA, USA Read the full story

Eisai and Biogen Idec ink a pharma deal for Alzheimer’s disease

Tags: , , ,


Eisai and Biogen Idec have entered into a pharma deal to develop and commercialize two of Eisai’s clinical candidates for Alzheimer’s disease (AD), E2609 and BAN2401. Read the full story

Biogen Idec and UCB make a pharma alliance pact

Tags: , , , ,


Biogen Idec and UCB have signed exclusive pharma alliance agreements granting UCB the right to commercialize Biogen Idec products. Read the full story

Pharma licensing deal between Biogen Idec and Sangamo

Tags: , , , ,


Biogen Idec and Sangamo BioSciences announced an exclusive worldwide Pharma licensing and collaboration agreement focused on the development of therapeutics for hemoglobinopathies for $320 million. Read the full story

Biogen Idec forms a pharma alliances with Proteostasis Therapeutics

Tags: , , ,


A pharma alliances is created between Biogen Idec and Proteostasis Therapeutics for Alzheimer's treatment. Read the full story

Biogen Idec pharma partners Amicus for Parkinson’s Disease collaboration

Tags: , , ,


Amicus Therapeutics has entered a collaboration with pharma partners Biogen Idec to discover, develop and commercialize novel small molecules for the treatment of Parkinson's disease. Read the full story